Chandan Diagnostic Strengthens Its National Footprint: 32 New Centres with Jeena Sikho from November 1 — Aiming for 40 by 2026

In the dynamic landscape of Indian healthcare, accessibility and integration are not optional, but they are rather required. Thus, Chandan Healthcare Limited takes a significant step forward by establishing an exclusive partnership with Jeena Sikho Lifecare Limited which plans the launch of 32 new diagnostic centers by 1 November and intends to reach 40 centers by 2026. These plans include offering modern diagnostics, which administrates both pathology and radiology, to the hospitals and clinics of India. Thus, the integrated strengths of two players in the field aim to revolutionize the system.

Nationwide Diagnostic Network Building

To the best of my understanding and knowledge from the publicly shared graphic and corporate disclosures, the alliance will be established to develop an integrated diagnostic network across all existing and future Jeena Sikho hospitals and clinics. Chandan will turn to the only provider of diagnostics at these weapon system installations, offering an end-to-end mix of radiology and pathology services covering both vertically (IPD) and horizontal comprehensive (OPD) aspects. In other words, when a patient walks into the Jeena Sikho clinic for her annual mammogram or is admitted to the Jeena Sikho hospital for dengue fever, the diagnostic provision will be fully integrated into the physical infrastructure. The objective is equally clear: quicker turnaround times for satisfactory reports, steady product output, and a one-stop search for diagnostics and treatment.

Why This Partnership Matters

Firstly, diagnostics are increasingly recognised as a critical part of the care-journey. Early detection and accurate imaging or lab results can make the difference between simple management and complex treatment. By ensuring diagnostics are available in the same institution where care is provided, delays reduce, and coordination improves.

Secondly, the geographic reach of Jeena Sikho’s network — combined with Chandan’s diagnosticsexpertise — means that not just major metros, but tier-2 and tier-3 regions stand to gain. Often, delays in referrals or sample transport are hurdles in smaller towns; having diagnostics embedded within a familiar and trusted clinic or hospital network can significantly change the patient experience.

Third, the pursued scale is both ambitious and targeted. The total of 32 new centers by 1 November means a prompt scaling, while the number of 40 by 2026 gives hope for a further continued effort rather than a one-time endeavor. This kind of measured growth supports future stability, rather than just fast growth without infrastructure.

What Patients Can Expect

For the patient, the changes will be tangible. Some of the key benefits include:

• Convenience: No longer needing to visit a separate diagnostic lab after a hospital appointment. Diagnostics are embedded within the same healthcare facility patients already trust.
• Integrated Care: When hospitals or clinics work closely with diagnostic units, test results are shared faster, enabling quicker and more accurate medical decisions.
• Wider Patient Coverage: Even though facilities may be based in different regions, a larger number of patients can gain access to quality diagnostic services.
• Comprehensive Services: The partnership offers complete pathology services (blood tests, biochemistry, etc.) along with radiology services (imaging and scans), ensuring a full-service diagnostic solution rather than a limited offering.

Technology, Quality & Trust

Quality in diagnostics doesn’t just happen; it comes from standardised protocols, well-maintained equipment, skilled lab-technicians and radiologists, and tight quality-control systems. Chandan has publicly emphasised its commitment to technology-enabled diagnostics and patient-centric service. With the Jeena Sikho network, those standards will now be scaled to multiple cities across the country.

The rollout graphic emphasises three pillars: Expanding National Footprint, Strengthening Diagnostic Leadership, and Empowering Holistic Patient Care. These aren’t just buzzwords — they reflect a strategy that combines reach (locations), capability (leadership/quality) and patient-outcome (holistic care). By aligning diagnostics with the broader care-ecosystem of Jeena Sikho (which includes clinics, hospitals, wellness services), the collaboration underscored the move toward “care as an experience,” not just diagnostics as a service.

Strategic Implications & Growth Path

For Chandan, the partnership acts as a key acceleration lever for national growth. Diagnostic networks often require large capital investment in labs, equipment, trained human resources and logistics. In this way, by tapping into JS’s, the model actually becomes much more scalable due to shared infrastructure, and patient-flow synergies. On the JS side, diagnostics are a logical next step too. Since clinics and hospitals are frequently referring patients out for testing, by integrating diagnostics in-house, they get control over quality, turnaround time, and thus patient satisfaction. It’s a competitive differentiator in a crowded healthcare market.

By targeting 40 centres by 2026, the partners are signalling long-term commitment, not just a one-time launch. The interim target of 32 by November serves as a near-term milestone to ensure momentum and execution.

What the Next Phase Might Look Like

As these centres open, attention will shift to operational excellence — how quickly test results are delivered, how often patients require re-tests, how effectively the staff manage sample logistics, and how smoothly hospital-diagnostic coordination works. Success in the first wave will set the foundation for wider adoption across the ramp and potentially more beyond the 40-centre target. Also, with diagnostics more seamlessly integrated, there are opportunities: preventive health packages, wellness screening integrated with clinics, short targeted imaging drives in regional centers and possibly home-sample collection push enabled by the network.

The business tie-up between Chandan Healthcare Limited and Jeena Sikho Lifecare Limited is more than a mere business. It represents a shift in thinking of how diagnostics are placed within the patient journey. By limiting the role of diagnostics within this process to post facto, Chandan and Jeena Sikho intend to see better, faster, and fairer testing throughout India.

All of this adds up to less hassle for patients across towns and cities, faster answers, and more close attention to organized care. It leads to greater efficiency and trusted networks for the system and more proactive diagnostics. In a market where readiness and nicely organized care are increasingly vital competitive benefits, this move puts both organizations solidly in pole position. Seventy centers are scheduled to be operational on 1 November, and 40% more in the pipeline between now and 2026, contrasting a new plan of diagnostics in India defined by coordination, access, and quality.